Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial compares toothpaste containing 0.454% stannous fluoride with a regular fluoride toothpaste containing 0.76% sodium monofluorop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colgate sodium monofluorophosphate toothpaste (sodium monofluorophosphate)
  • Colgate stannous fluoride toothpaste (stannous fluoride)

Snippet

Sponsor: Colgate Palmolive | Conditions: Calculus, Dental | Phase 2, Phase 3 | Status: COMPLETED